NeisVac-C Single Prime Study in Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to assess the feasibility of a single priming dose of NeisVac-C in infants (at either 4 or 6 months of age), as determined by immune response.
Epistemonikos ID: 86c57bc02e3a6d8618266bee27e5f0ccebf5b7da
First added on: May 06, 2024